|
5-ALA Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Alpheus Medical, Inc.1
Indications
- Bihemispheric GBM1
- Butterfly GBM1
- bGBM1
- Glioblastom WHO Grade 41
- GBM1
Buffalo, New York1 trial
TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
Dent Neurologic Institute
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.